Archive for February 22nd, 2011

FDA refuses to file DCTH NDA. CLDA acquired. FURX SNTS INFI DVAX news

Feb 22, 2011 No Comments by

Furiex Pharmaceuticals, Inc. (Nasdaq: FURX) was added to the Clinical Database following release of 4Q 2010 results today. They initiated a Phase 2 proof-of-concept study in January for PPD-10558 for the treatment of dyslipidemia in patients who experience statin associated myalgia. FURX also recently obtained FDA Fast Track Designation of MuDelta for the treatment of […]

Daily News Read more